Literature DB >> 19472280

Computational structural analysis of an anti-L-amino acid antibody and inversion of its stereoselectivity.

Daniel I Ranieri1, Heike Hofstetter, Oliver Hofstetter.   

Abstract

The binding site of a monoclonal anti-L-amino acid antibody (anti-L-AA) was modeled using the program SWISS-MODEL. Docking experiments with the enantiomers of phenylalanine revealed that the antibody interacts with L-phenylalanine via hydrogen bonds and hydrophobic contacts, whereas the D-enantiomer is rejected due to steric hindrance. Comparison of the sequences of this antibody and an anti-D-amino acid antibody (anti-D-AA) indicates that both immunoglobulins derived from the same germline progenitor. Substitution of four amino acids residues, three in the framework and one in the complementarity determining regions (CDRs), allowed in silico conversion of the anti-L-AA into an antibody that stereoselectively binds D-phenylalanine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19472280      PMCID: PMC2769206          DOI: 10.1002/jssc.200800694

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  46 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  A new model for protein stereospecificity.

Authors:  A D Mesecar; D E Koshland
Journal:  Nature       Date:  2000-02-10       Impact factor: 49.962

Review 3.  Stereoselectivity of drug-receptor interactions.

Authors:  Willem Soudjin; Ineke van Wijngaarden; A P IJzerman
Journal:  IDrugs       Date:  2003-01

4.  Comparative evaluation of eight docking tools for docking and virtual screening accuracy.

Authors:  Esther Kellenberger; Jordi Rodrigo; Pascal Muller; Didier Rognan
Journal:  Proteins       Date:  2004-11-01

5.  Improvement of cyclophosphamide activation by CYP2B6 mutants: from in silico to ex vivo.

Authors:  Thien-An Nguyen; Marina Tychopoulos; Florence Bichat; Clothilde Zimmermann; Jean-Pierre Flinois; Monique Diry; Emelie Ahlberg; Marcel Delaforge; Laurent Corcos; Philippe Beaune; Patrick Dansette; François André; Isabelle de Waziers
Journal:  Mol Pharmacol       Date:  2008-01-22       Impact factor: 4.436

6.  Molecular modeling of antibody combining sites.

Authors:  A C Martin; J C Cheetham; A R Rees
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

7.  The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1994-06       Impact factor: 3.686

8.  Humanization of an anti-CD34 monoclonal antibody by complementarity-determining region grafting based on computer-assisted molecular modelling.

Authors:  Sheng Hou; Bohua Li; Ling Wang; Weizhu Qian; Dapeng Zhang; Xueyu Hong; Hao Wang; Yajun Guo
Journal:  J Biochem       Date:  2008-04-19       Impact factor: 3.387

9.  Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.

Authors:  Michael Zemlin; Martin Klinger; Jason Link; Cosima Zemlin; Karl Bauer; Jeffrey A Engler; Harry W Schroeder; Perry M Kirkham
Journal:  J Mol Biol       Date:  2003-12-05       Impact factor: 5.469

10.  SEROLOGICAL DIFFERENTIATION OF STERIC ISOMERS.

Authors:  K Landsteiner; J van der Scheer
Journal:  J Exp Med       Date:  1928-08-31       Impact factor: 14.307

View more
  1 in total

1.  Conformational adaptability determining antibody recognition to distomer: structure analysis of enantioselective antibody against chiral drug gatifloxacin.

Authors:  Lanteng Wang; Wei Xie; Wenyang Jiao; Chijian Zhang; Xiangmei Li; Zhenlin Xu; Xin-An Huang; Hongtao Lei; Xing Shen
Journal:  RSC Adv       Date:  2021-12-13       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.